Glenmark Pharmaceuticals consolidated net profit rises 15.88% in the December 2025 quarter
Sales rise 17.75% to Rs 3888.00 crore
Net profit of Glenmark Pharmaceuticals rose 15.88% to Rs 403.21 crore in the quarter ended December 2025 as against Rs 347.96 crore during the previous quarter ended December 2024. Sales rose 17.75% to Rs 3888.00 crore in the quarter ended December 2025 as against Rs 3301.90 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales3888.003301.90 18 OPM %22.3718.18 -PBDT872.79579.06 51 PBT718.34456.33 57 NP403.21347.96 16Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 31 2026 | 9:11 AM IST